Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma

Ipilimumab, a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody that potentiates antitumor T-cell responses, has demonstrated improved survival in previously treated and treatment-naïve patients with unresectable stage III/IV melanoma. Survival benefit has also been shown in dive...

Descripción completa

Detalles Bibliográficos
Autor principal: Chmielowski, Bartosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665248/
https://www.ncbi.nlm.nih.gov/pubmed/23738073
http://dx.doi.org/10.1155/2013/423829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665248/
https://www.ncbi.nlm.nih.gov/pubmed/23738073
http://dx.doi.org/10.1155/2013/423829

Ejemplares similares